AVANGRID Reports Full Year and Fourth Quarter 2017 Earnings Results and Provides 2018 Earnings Outlook

non-U.S. GAAP consolidated adjusted net income was $682 million, or $2.20 per share, for the year ended December 31, 2017, compared to $643 million, or $2.08 per share, for the same period in 2016, a 6% increase. For the fourth quarter ended December 31 ...

Free Research Report as Quest Diagnostics’ Q4 Adjusted EPS Grew 6.9% Y-o-Y and Outshone Forecasts

Meanwhile, the Company reported an adjusted net income attributable to common shareholders of $740 million, or $5.67 per diluted share, in FY17 compared to $682 million, or $5.15 per diluted share, in FY16. For the reported quarter, the Company's cost of ...

Active-Investors: Free Research Report as Quest Diagnostics' Q4 Adjusted EPS Grew 6.9% Y-o-Y and Outshone Forecasts

Meanwhile, the Company reported an adjusted net income attributable to common shareholders of $740 million, or $5.67 per diluted share, in FY17 compared to $682 million, or $5.15 per diluted share, in FY16. For the reported quarter, the Company's cost of ...